中间时期
发表于 2025-3-21 16:30:32
书目名称Chirurgisches Forum 2002影响因子(影响力)<br> http://impactfactor.cn/2024/if/?ISSN=BK0226051<br><br> <br><br>书目名称Chirurgisches Forum 2002影响因子(影响力)学科排名<br> http://impactfactor.cn/2024/ifr/?ISSN=BK0226051<br><br> <br><br>书目名称Chirurgisches Forum 2002网络公开度<br> http://impactfactor.cn/2024/at/?ISSN=BK0226051<br><br> <br><br>书目名称Chirurgisches Forum 2002网络公开度学科排名<br> http://impactfactor.cn/2024/atr/?ISSN=BK0226051<br><br> <br><br>书目名称Chirurgisches Forum 2002被引频次<br> http://impactfactor.cn/2024/tc/?ISSN=BK0226051<br><br> <br><br>书目名称Chirurgisches Forum 2002被引频次学科排名<br> http://impactfactor.cn/2024/tcr/?ISSN=BK0226051<br><br> <br><br>书目名称Chirurgisches Forum 2002年度引用<br> http://impactfactor.cn/2024/ii/?ISSN=BK0226051<br><br> <br><br>书目名称Chirurgisches Forum 2002年度引用学科排名<br> http://impactfactor.cn/2024/iir/?ISSN=BK0226051<br><br> <br><br>书目名称Chirurgisches Forum 2002读者反馈<br> http://impactfactor.cn/2024/5y/?ISSN=BK0226051<br><br> <br><br>书目名称Chirurgisches Forum 2002读者反馈学科排名<br> http://impactfactor.cn/2024/5yr/?ISSN=BK0226051<br><br> <br><br>
加剧
发表于 2025-3-21 22:33:56
http://reply.papertrans.cn/23/2261/226051/226051_2.png
BUOY
发表于 2025-3-22 02:10:06
S. R. Kane,Y. Uchida,H. S. Hudsonplicative H2B expression following partial hepatectomy. Egr-1 was specifically induced in non-deprived lobes 1 h following portal branch ligation, and to a higher extent following partial hepatectomy. PRL-1 expression peaked 3 h after partial hepatectomy and portal branch ligation in the non-deprive
Essential
发表于 2025-3-22 05:03:49
http://reply.papertrans.cn/23/2261/226051/226051_4.png
Amylase
发表于 2025-3-22 10:37:58
A. H. Gabriel,E. Antonucci,L. Steenman-Clarkteriolar and venular diameter, venular red blood cell velocity, functional capillary density and leukocyte-endothelium interaction were determined by intravital fluorescence microscopy; in addition, macrohemodynamics and blood gases were assessed. Values are given as mean ± SD. Friedman ANOVA and Du
轻而薄
发表于 2025-3-22 16:49:45
Thermal Evolution of Flare Plasmareated with rhBMP-2/ACS experienced significantly fewer secondary interventions (dose-dependent overall rate reduction; .= 0.0017). Patients receiving rhBMP-2/ACS (1.50 mg/mL) had a 44% reduced risk of secondary intervention compared to SC control patients (RR = 0.56; 95% CI = 0.40 to 0.78; pairwise
轻而薄
发表于 2025-3-22 18:24:47
http://reply.papertrans.cn/23/2261/226051/226051_7.png
欢呼
发表于 2025-3-22 23:59:17
http://reply.papertrans.cn/23/2261/226051/226051_8.png
担忧
发表于 2025-3-23 01:26:30
http://reply.papertrans.cn/23/2261/226051/226051_9.png
精美食品
发表于 2025-3-23 07:07:31
http://reply.papertrans.cn/23/2261/226051/226051_10.png